AZITHROMYCIN AND CO-AMOXICLAV AT DIFFERENT DOSAGES HAVE BEEN PROMOTED FOR TREATING CHILDREN WITH LOWER RESPIRATORY TRACT INFECTIONS. CDF [Internet]. 2026 Feb. 10 [cited 2026 Feb. 25];53(02):5041-6. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/3961